SDS changes the analytical basis of electrophoresis by denaturing proteins and giving them a uniform negative charge. Because charge differences are reduced, movement through the polyacrylamide gel primarily reflects protein size. This separation allows a target protein to be examined at a position related to its molecular size before antibody-based detection on the membrane.
Target recognition depends on two antibody stages. The primary antibody selects the protein of interest, whereas the labeled secondary antibody provides the detectable signal associated with that bound primary antibody. Keeping these roles conceptually separate helps researchers distinguish molecular recognition from signal generation and supports selective analysis when several proteins are present.
Controls and normalization address two different interpretive problems. Controls help determine whether an observed signal is specific rather than reflecting unexplained variation, while normalization helps account for variation when comparing samples. Together, they make differences in protein expression more credible and are especially important when medical studies assess molecular changes across conditions.
A typical workflow moves from protein treatment to separation, transfer, and detection. Proteins are treated with sodium dodecyl sulfate, electrophoresed through a polyacrylamide gel, and transferred to a membrane. The membrane is then probed with a primary antibody and a labeled secondary antibody, creating a sequence that links size-based separation with target-specific identification.
SDS-PAGE immunoblotting can support biomarker validation by showing whether a selected protein signal is present and how its expression differs among studied samples. The separation step helps locate the target relative to protein size, while antibody detection focuses the analysis on that target. This combination makes the method useful when evaluating candidate molecular indicators in medical research.
In disease mechanism studies, the method can help examine protein expression and molecular changes associated with a medical condition. In therapeutic-response research, the same type of target-specific measurement can be used to evaluate molecular changes linked to treatment. These applications do not rely on signal alone: appropriate controls and normalization are needed to interpret differences reliably.